Expression of human MutT homologue (hMTH1) protein in primary non-small-cell lung carcinomas and histologically normal surrounding tissue

Kennedy, Christopher H.; Pass, Harvey I.; Mitchell, James B.

doi:10.1016/s0891-5849(03)00176-x

Cited by 57 publications

(41 citation statements)

References 54 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The outcome of such damage in vitro is misreplication, inhibition of replication, or mutagenesis described as "action-at-adistance." DNA containing 8-oxo-dG can also be formed by misincorporation of 8-oxo-dGTP via DNA polymerases (52). Reports of levels of 8-oxo-guanine or 8-oxo-dG in human tissues range from one adduct in 10 7 nucleotides to one adduct in 10 3 nucleotides.…”

Section: Adducts As Biomarkers Of Carcinogenesis and Chemopreventionmentioning

confidence: 99%

Biological Relevance of Adduct Detection to the Chemoprevention of Cancer

Sharma

Farmer

2004

Clinical Cancer Research

View full text Add to dashboard Cite

show abstract

Section: Adducts As Biomarkers Of Carcinogenesis and Chemopreventionmentioning

confidence: 99%

Biological Relevance of Adduct Detection to the Chemoprevention of Cancer

Sharma

Farmer

2004

Clinical Cancer Research

View full text Add to dashboard Cite

show abstract

“…Although MTH1 is non-essential in normal cells, cancer cells require MTH1 activity to avoid the incorporation of oxidized dNTPs, which would result in DNA damage and cell death (12)(13)(14). By aiming at a redox-adaptation mechanism, MTH1 inhibition represents a new approach for a therapeutic strategy against cancer (15,16 …”

Section: Introductionmentioning

confidence: 99%

TH588, an MTH1 inhibitor, enhances phenethyl isothiocyanate‑induced growth inhibition in pancreatic cancer cells

et al. 2017

View full text Add to dashboard Cite

Abstract. Chemotherapy and radiotherapy are the most common approaches in cancer therapy. They may kill cancer cells through the generation of high levels of reactive oxygen species (ROS), which leads to oxidative DNA damage. However, tumor resistance to ROS is a problem in cancer therapy. MTH1 sanitizes oxidized dNTP pools to prevent the incorporation of damaged bases during DNA replication. Although MTH1 is non-essential in normal cells, cancer cells require MTH1 activity to avoid the incorporation of oxidized dNTPs, which would result in DNA damage and cell death. By targeting a redox-adaptation mechanism, MTH1 inhibition represents a novel therapeutic strategy against cancer. However, recent reports have indicated that growth inhibition by MTH1 inhibitors may be due to off-target cytotoxic effects. TH588, one of the first-in-class MTH1 inhibitors, kills cancer cells by an off-target effect. However, a low concentration of TH588 may effectively inhibit MTH1 activity without inhibiting cell proliferation. Phenethyl isothiocyanate (PEITC) is a dietary anticarcinogenic compound and an inducer of ROS. In the present study, it has been demonstrated that combined treatment with PEITC and TH588 effectively inhibited the growth of pancreatic cancer MIAPaCa-2 and Panc-1 cells. The antioxidant N-acetylcysteine negated this synergistic growth inhibition. PEITC and TH588 cooperatively induced the formation of 8-oxo-deoxyguanine in nuclei and pH2AX foci, a marker of DNA damage. However, the combined effects are not associated with MTH1 mRNA expression in several cancer cell lines, suggesting that the possibility of an off-target effect of TH588 cannot be eliminated. These results suggest that the combination of PEITC and TH588 has potential as a novel therapeutic strategy against pancreatic cancer. IntroductionPancreatic cancer remains a highly lethal neoplasm. Even with multimodality therapy for localized disease, patient survival is measured in months. Although the FOLFIRINOX regimen has produced substantial benefits in the treatment of metastatic pancreatic cancer, it is associated with severe adverse effects (1). The further development of better therapeutic regimens for pancreatic cancer requires new and potent anticancer agents.Ras transformation renders cells sensitive to reactive oxygen species (ROS)-induced cell death (2,3), and pancreatic cancers exhibit an extremely high mutation rate of K-ras (>90%) (4). Therefore, we investigated the anti-proliferative effects of ROS generators on pancreatic cancer cells. Phenethyl isothiocyanate (PEITC) is a potent ROS generator (5-8). PEITC belongs to the family of natural isothiocyanates, which are found in a variety of cruciferous vegetables and released when the vegetables are cut or masticated (5). PEITC has an inhibitory effect on the growth of several types of cancer cells, and is now being studied in phase 2 clinical trials for the prevention of lung and oral cancer (3,(5)(6)(7)(8). ROS results in the oxidation of cell constituents such as DNA, lipids and proteins, a...

show abstract

“…A higher level of MTH1 has generally been observed in cancerous cells compared to normal cells [47]. For instances, the expression of MTH1 mRNA in tumors including renal-cell carcinomas [48], brain tumors [49], lung cancers [50,51], gastric cancer [52] and esophageal squamous cell carcinomas [53] is considerably higher than that in adjacent normal tissues. These observations suggest that tumor cells rely strongly on sanitization of their nucleotide pools for proper growth.…”

Section: Mth1 Mth2mentioning

confidence: 99%

Hepatitis B Virus X Protein Increases 8-Oxo-7,8-Dihydro-2ʹ-Deoxyguanosine (8-Oxodg) Level via Repressing MTH1/ MTH2 Expression in Hepatocytes

Lin

Liu

et al. 2018

Cell Physiol Biochem

View full text Add to dashboard Cite

Background/Aims: Chronic hepatitis B virus (HBV) infection markedly increases the risk of development of hepatocellular carcinoma (HCC). Among the seven viral proteins that HBV encodes, HBV X protein (HBx) appears to have the most oncogenic potential. The mitochondria-associated HBx can induce oxidative stress in hepatocytes, leading to the production of abundant reactive oxygen species (ROS). High levels of ROS usually induce oxidative DNA damage and 8-hydroxy-2-deoxyguanosine (8-OHdG), also known as 8-oxo-7,8-dihydro-2-deoxyguanosine (8-oxodG), which is one of the major products of DNA oxidation and an important biomarker for oxidative stress and carcinogenesis. Cells have evolved a mechanism to prevent oxidized nucleotides from their incorporation into DNA through nucleotide pool sanitization enzymes of MTH1 (NUDT1), MTH2 (NUDT15), MTH3 (NUDT18) and NUDT5. However, little is known as to whether HBx can regulate the expression of those enzymes and modulate the formation and accumulation of 8-oxodG in hepatocytes. Methods: The level of 8-oxodG was assessed by ELISA in stable HBV-producing hepatoma cell lines, an HBV infectious mouse model, HBV and HBx transgenic mice and HBV-infected patients versus their respective controls. Expression of MTH1, MTH2, MTH3 and NUDT5 was determined by a real-time quantitative PCR and western blot analysis. Transcriptional regulation of MTH1 and MTH2 expression by HBx and the effect of HBx on MTH1 and MTH2 promoter hypermethylation were examined using a luciferase reporter assay and bisulfite sequencing analysis. Results: In comparison with controls, significantly higher levels of 8-oxodG were detected in the genome and culture supernatant of stable HBV-producing HepG2.2.15 cells, in the sera and liver tissues of HBV infectious mice and HBV or HBx transgenic mice, and in the sera of HBV-infected patients. Expression of HBx in hepatocytes significantly increased 8-oxodG level and reduced the expression of MTH1 and MTH2 at both mRNA and protein levels. It was also demonstrated that HBx markedly attenuated the MTH1 or MTH2 promoter activities through hypermethylation. Furthermore, enhancement of 8-oxodG production by HBx was reversible by overexpression of MTH1 and MTH2. Conclusion: Our data show that HBx expression results in the accumulation of 8-oxodG in hepatocytes through inhibiting the expression of MTH1 and MTH2. This may implicate that HBx may act as a tumor promoter through facilitating the mutational potential of 8-oxodG thus connecting a possible link between HBV infection and liver carcinogenesis.

show abstract

Expression of human MutT homologue (hMTH1) protein in primary non-small-cell lung carcinomas and histologically normal surrounding tissue

Cited by 57 publications

References 54 publications

Biological Relevance of Adduct Detection to the Chemoprevention of Cancer

Biological Relevance of Adduct Detection to the Chemoprevention of Cancer

TH588, an MTH1 inhibitor, enhances phenethyl isothiocyanate‑induced growth inhibition in pancreatic cancer cells

Hepatitis B Virus X Protein Increases 8-Oxo-7,8-Dihydro-2ʹ-Deoxyguanosine (8-Oxodg) Level via Repressing MTH1/ MTH2 Expression in Hepatocytes

Contact Info

Product

Resources

About